When to Talk About The End
One of the stark and sad realities of cancer is that not everybody beats it. Knowing that the end could be near and talking about it may be a wise choice for some.
Sipping Away Cancer Risks
Drinking green tea has been associated with everything from longer life to improving memory. It’s healthy stuff that may keep our DNA strong. Green tea may be adding a new anti-cancer benefit to its resumé.
Realistic Expectations Are a Good Thing
Hope is an important part of fighting cancer. But unrealistic optimism in the final stages of cancer can influence important patient decisions.
Aspirin May Be a Cancer Knock-Out
Colorectal cancer is one of the diseases that daily aspirin therapy may prevent. This inexpensive over-the-counter drug may now be useful in helping some colorectal cancer patients live longer.
Folic Acid and B Vitamins Don’t Cut Cancer Risks
We just learned recently that long-term use of multivitamins helps lower the risk of cancers in men 50 years and older. A new study finds that a specific supplement doesn’t offer much help.
Red Meat For Bladder Cancer
High red meat consumption has been associated with increasing a person’s risk of particular cancers. Another form of the disease has been added to the list.
The Lost Years of Cancer
The big C takes a chunk out of human life, wherever it appears – in whatever form. The lost years and the lost productivity take their toll not just on individuals and their families – but the entire world.
Should Aspirin Be Used to Prevent Colorectal Cancer?
Increasingly, scientists are linking inflammation with cancer. A classic drug choice to treat inflammation is aspirin. Is this drug ready for primetime in the cancer fight? Well, it depends who you ask.
A Chat With The Makers Of New Colorectal Cancer Drug
People living with colorectal cancer that has spread to other areas of the body now have a new therapy option. Unlike so many late-stage cancer treatments, this isn’t an intravenous drug - rather, a tablet.
FDA approves new treatment for advanced colorectal cancer
The US Food and Drug Administration today approved Stivarga (regorafenib) to treat patients with colorectal cancer that has progressed after treatment and spread to other parts of the body (metastatic).